A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

Exact Sciences Corporation EXAS is well-poised to grow in the coming quarters, courtesy of its continuous investment in R&D efforts. In addition, EXAS’ commercial capabilities are driving stronger ...

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their ...

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.

Arizona is in the process of trying to sell naming rights to Arizona Stadium. Don’t expect the deal, when done, to wash away the UA’s debt service. Penn State last week announced it has received a $50 ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

As a golfer, Tom Lehman is trained to always think about the next shot or the next big tournament. Lehman, 58, did something different as he prepared for Friday’s first round of the Cologuard Classic.